VIDEO: TNF inhibitors improved refractory skin disease in juvenile dermatomyositis

LONDON – Tumor necrosis factor–inhibitor treatment improved refractory skin disease in juvenile dermatomyositis patients in the largest observational study of its kind from the United Kingdom and...
Source: Pediatric News - Category: Journals (General) Source Type: news